DOSIsoft, leading provider of patient-specific imaging and dosimetry software solutions for radiation oncology and nuclear medicine, is proud to be part of the EU-funded Thera4care Project - a public-private initiative aiming to revolutionize precision oncology and establish Europe as a global leader in Theranostics, a cutting-edge approach combining diagnostics with targeted therapies to enable personalized treatments.
Contributing with its own R&D and granted €1,6 million of EU funding, DOSIsoft will focus its efforts on the further development of dosimetry software, sharing the vision that personalized dosimetry becomes a standard clinical practice.
Thera4care: Development and proof of principle of new clinical applications of theranostics solution
Ad Statistics
Times Displayed: 80930
Times Visited: 5347 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Scheduled for 5 years and composed of 9 workpackage (WP), Thera4care brings together 29 partners from well-established European academic centers, research organizations, healthcare providers, SMEs, strong industry stakeholders and patient advocacy groups - a unique consortium with multidisciplinary knowledge - capable to develop and translate new radiotheranostic concepts, improve patient benefits and broaden access throughout Europe. Simultaneously, Thera4care is committed to developing standardized and scalable dosimetry, quantification, therapy-selection, and timely supply methodologies to ensure precise treatment and optimize patient outcomes.
Currently, radionuclide-based therapies are limited to a few specialized centers with the need to increase clinical treatment capacities, and to widen the arsenal of radiotheranostics. Thera4care has the ambition to expand understanding of dosimetry, with focus on 177Lu-PSMA treatment, establish a robust methodological foundation for alpha-radiopharmaceutical dosimetry, and advance the clinical routinary application of radiotheranostics.
DOSIsoft: a dedicated involvement in “Dosimetry software development”
Perfectly sharing the Thera4Care’s vision, DOSIsoft plays a key role in WP7 dedicated to “Dosimetry” studies, especially contributing to one of the project’s overarching objectives: “enhancing clinical outcomes through AI-based imaging and personalized dosing protocols”.
By bringing its more than 20 years of software technological prowess and strong dosimetry expertise, DOSIsoft is assigned to the specific task (WP7.8) - “Dosimetry software development” - to advance novel dosimetric concepts & improved imaging equipment. The high-level clinical results are expected to provide standard protocols for imaging, simple and automatic dosimetry as well as dose adjustment ability:
